<DOC>
	<DOC>NCT02527369</DOC>
	<brief_summary>This study was designed to demonstrate safety and efficacy of the XP1100RF for non-invasive temporary reduction of thighs circumference by disruption of adipocyte cells.</brief_summary>
	<brief_title>Effect of the XP1100RF Therapy on Thighs Circumference Reduction</brief_title>
	<detailed_description>This study is a prospective, single-arm, open label study of thighs circumference reduction following 4 treatment sessions delivered once a week over a 4-week period. The objective of the study is to demonstrate the effectiveness of the treatment after 30-day in achieving thighs circumference reduction of â‰¥1 cm relative to the base line assessment.</detailed_description>
	<criteria>Body Mass Index (BMI) of 20 to 35 kg/m2. Subjects willing and able to abstain from partaking in any treatments other than the study procedure to promote body contouring and/or weight loss during study participation. Subjects willing and able to maintain his/her regular (preprocedure) diet and exercise regimen without effecting significant change in either direction during study participation. Implanted electronic device such as a cardiac pacemaker, bladder stimulator, spinal cord stimulator or electrodes for a myoelectric prosthesis, etc. Diabetics dependent on insulin or oral hypoglycemic medications Known cardiovascular disease such as arrhythmias, congestive heart failure Cardiac surgeries such as cardiac bypass, heart transplant surgery, pacemakers. Prior surgical interventions for body sculpting of thighs such as liposuction Medical, physical or other contraindications for body sculpting/ weight loss Current use of medication known to affect weight levels and/or cause bloating or swelling and for which abstinence during the course of study participation is not safe or medically prudent Any medical condition known to affect weight levels and/or to cause bloating or swelling Active infection, wound or other external trauma to the area to be treated Pregnant, breast feeding, or planning pregnant before the end of the study Serious mental health illness Active or recurrent cancer or current chemotherapy and/or radiation treatment Negative affection to heat</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Fat Reduction</keyword>
	<keyword>Lipolysis</keyword>
</DOC>